O4‐11‐06: A RANDOMIZED, DOUBLE‐BLIND, PLACEBO‐CONTROLLED PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CRENEZUMAB IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE. (1st July 2014) - Cummings, Jeffrey; Cho, William; Ward, Michael; Friesenhahn, Michel; Brunstein, Flavia; Honigberg, Lee; Clayton, David; Mortensen, Deborah; Ho, Carole; Paul, Robert